Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Reviva Pharmaceuticals Holdings, Inc. RVPH
$7.40
-$0.49 (-6.57%)
На 18:04, 12 мая 2023
+35.14%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
173024766.00000000
-
week52high
9.25
-
week52low
0.53
-
Revenue
0
-
P/E TTM
-7
-
Beta
0.10113800
-
EPS
-1.35000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 10:59
Описание компании
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 24 янв 2022 г. | |
| Maxim Group | Buy | 26 июл 2021 г. | |
| Maxim Group | Buy | Buy | 01 ноя 2022 г. |
| Alliance Global Partners | Buy | 01 ноя 2022 г. | |
| HC Wainwright & Co. | Buy | 25 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Patel Purav | A | 43547 | 3000 | 18 ноя 2022 г. |
| SAXENA PARAG | A | 3900 | 3900 | 10 ноя 2022 г. |
| Funtleyder Leslie D. | A | 3900 | 3900 | 10 ноя 2022 г. |
| Margolin Richard A | A | 3900 | 3900 | 10 ноя 2022 г. |
| Patel Purav | A | 3900 | 3900 | 10 ноя 2022 г. |
| Narayan Prabhu | A | 100000 | 50000 | 30 сент 2022 г. |
| VEDANTA PARTNERS, LLC | A | 513834 | 513834 | 08 сент 2022 г. |
| VEDANTA PARTNERS, LLC | A | 869565 | 869565 | 08 сент 2022 г. |
| VEDANTA PARTNERS, LLC | A | 513834 | 513834 | 08 сент 2022 г. |
| VEDANTA PARTNERS, LLC | A | 869565 | 869565 | 08 сент 2022 г. |
Новостная лента
Reviva Pharmaceuticals to Present at the 2023 BIO CEO and Investor Conference
GlobeNewsWire
31 янв 2023 г. в 06:00
Cupertino, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the BIO CEO and Investor Conference being held February 6–9, 2023 in New York, NY. Please see additional details below:
4 Penny Stocks To Buy According To Analysts Right Now
PennyStocks
01 ноя 2022 г. в 10:18
Penny stocks with bullish analyst ratings. Time to buy or avoid entirely?
Reviva Pharmaceuticals to Present at the Lytham Partners Fall 2022 Investor Conference
GlobeNewsWire
26 сент 2022 г. в 06:00
CUPERTINO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Lytham Partners Fall 2022 Investor Conference being held September 28–29, 2022 and invites investors to participate via virtual one-on-one meetings. Please see additional details below:
Reviva Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
07 сент 2022 г. в 08:02
CUPERTINO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright Global Investment Conference being held September 12–14, 2022 and invites investors to participate via virtual one-on-one meetings or in-person in New York, NY. Please see additional details below:
Penny Stocks To Watch: Why REVB, RVPH, BARK, and GRAY Stock Are Moving
PennyStocks
09 авг 2022 г. в 14:11
Hot penny stocks to watch this week. The post Penny Stocks To Watch: Why REVB, RVPH, BARK, and GRAY Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.